Daily Star on MSN1h
King Charles' health history after hospital observation – from 'sausage fingers' to cancer blow
Buckingham Palace announced King Charles returned to hospital to treat temporary side effects of his cancer treatment - here, ...
BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...
Portage Biotech Shares More Than Double After Results of PORT-7 Tumor Treatment Trial
Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...
Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research
We recently published a list of Top 8 AI News Updates Driving Markets Today. In this article, we are going to take a look at ...
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...
A mother runs for her daughter: ‘She’s stronger and fiercer than I ever imagined’
Beth McKenna's daughter was born with Neurofibromatosis Type 1 (NF1). She's running the Boston Marathon for the Children's ...
Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting
Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...
AFRO American Newspapers6h
What is glioblastoma, the aggressive brain cancer that killed former U.S. Rep. Mia Love?
Former U.S. Rep. Mia Love, a pioneering Black Republican, died at 49 from aggressive brain cancer. Her death raises awareness ...
UC Cancer Center, Dana-Farber, more receive $1.2 million from family foundation
The University of Cincinnati Cancer Center and other research powerhouses have received a million-dollar grant.
Targeted Oncology6h
Leronlimab Gets FDA Nod for Phase 2 Microsatellite-Stable CRC Trial
A phase 2 trial will evaluate leronlimab’s safety and efficacy for the treatment of patients with microsatellite stable ...
Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ̶ Strong Outlook for 2025
Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...
Surgeon Drops Part of Woman’s Skull During Surgery, Puts It Back In: ‘Three-Second Rule’
Abi Feltham, 37, nicknamed her surgeon “Dr. Butterfingers” after learning that her accidentally dropped a fragment of her ...